Pricing
  1. US-listed companies
  2. Avid Bioservices, Inc.
  3. Financials
  4. EBITDA margin (%)

Avid Bioservices, Inc. (CDMO)

Market cap
$798.9M
P/E ratio
SummaryFinancials
Period EndEBITDA margin (%) YoY (%)
Apr 30, 2024-5.4-174.69%
Apr 30, 20237.2-56.48%
Apr 30, 202216.6+1.64%
Apr 30, 202116.4-224.53%
Apr 30, 2020-13.1+145.03%
Apr 30, 2019-5.4-84.08%
Apr 30, 2018-33.7-24.69%
Apr 30, 2017-44.8-63.52%
Apr 30, 2016-122.7-33.56%
Apr 30, 2015-184.7+19.15%
Apr 30, 2014-155+23.26%
Apr 30, 2013-125.7-53.47%
Apr 30, 2012-270.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat